Core Viewpoint - The proposed change of control at Yonghe Intelligent Control has been abruptly terminated due to the failure of Hangzhou Runfeng to fulfill payment obligations under the share transfer agreement [1][2] Group 1: Share Transfer Agreement - On August 5, a share transfer agreement was signed between Cao Delin and Hangzhou Runfeng, where Cao intended to transfer 35.66 million shares (8% of total shares) at approximately 8.97 yuan per share, totaling 320 million yuan [1] - The agreement included a voting rights delegation agreement, which would have resulted in a change of controlling shareholder from Cao Delin to Sun Rongxiang [1] - The transfer was contingent upon Hangzhou Runfeng making an initial payment of 20.01 million yuan, which was not completed, leading to the automatic invalidation of the agreement [2] Group 2: Company Control and Ownership - As of the announcement date, Cao Delin and his associates held 46.73 million shares, representing 10.49% of the total share capital, indicating that control remains unchanged [2] - The termination of the share transfer agreement ensures that Cao Delin continues as the controlling shareholder and actual controller of Yonghe Intelligent Control [2] Group 3: Company Background and Business Segments - Yonghe Intelligent Control was founded in 2003 and listed on the Shenzhen Stock Exchange in April 2016, initially focusing on fluid control equipment [2] - In 2019, the company expanded into the medical sector with a focus on precision radiation therapy for tumors [2] - In December 2022, Yonghe Intelligent Control became a controlling shareholder of Puluo New Energy Technology (Taixing) Co., Ltd., entering the photovoltaic industry, and currently operates in three main sectors: valves, medical, and photovoltaic [2] Group 4: Financial Performance - The company has projected a net loss of 30 million to 56 million yuan for the first half of 2025, indicating ongoing financial challenges [2]
永和智控易主事项突然告吹 实际控制人称交易对方迟迟不付钱